This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Topol, E. NHS Health Education England https://topol.hee.nhs.uk/ (2019).
Cipresso, P. et al. Front. Psychol. 9, 2086 (2018).
Yeung, A. W. K. et al. J. Med. Internet Res. 23, e25499 (2021).
Laver, K. E. et al. Cochrane Database Syst. Rev. 11, CD008349 (2017).
Rizzo, A. S. et al. Neuropsychology 31, 877–899 (2017).
Vasey, B. et al. Nat. Med. 28, 924–933 (2022).
Liu, X. et al. Nat. Med. 26, 1364–1374 (2020).
Birckhead, B. et al. JMIR Ment. Health 6, e11973 (2019).
McCulloch, P. et al. Lancet 374, 1105–1112 (2009).
Riva, G. et al. Cyberpsychol. Behav. Soc. Netw. 25, 355–359 (2022).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
B.G. has received consultancy and research grants from Philips and Edwards Lifesciences, and is owner and board member of Healthplus.ai and its subsidiaries. D.G. has received speaker fees and travel expenses from Dräger, GE Healthcare (medical advisory board 2009–2012), Maquet and Novalung (medical advisory board 2015–2018). All other authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Vlake, J.H., van Bommel, J., Riva, G. et al. Reporting the early stage clinical evaluation of virtual-reality-based intervention trials: RATE-VR. Nat Med 29, 12–13 (2023). https://doi.org/10.1038/s41591-022-02085-7
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41591-022-02085-7